Vyome Holdings (HIND) Research & Development (2015 - 2026)
Vyome Holdings (HIND) posted Research & Development of $506,723 for Q2 2026, up 532.9% from $80,061 a year earlier but down 24.0% from the prior quarter.
Powered by 
Analysis
Vyome Holdings (HIND) Research & Development (2015 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Research & Development at Vyome Holdings was $1.59 million, up 422.2% year-over-year; for FY2025, it was $588,258, up 106.1% from FY2024.
- Annual Research & Development shows a five-year compound annual growth rate of -30.0% (FY2020 to FY2025).
- In prior years, Vyome Holdings' Research & Development was $285,391 in FY2024 (-87.7%), $2.32 million in FY2023 (-8.8%), $2.54 million in FY2022 (+7.1%) and $2.37 million in FY2021 (-32.3%).
- Quarterly Research & Development has run from a low of $39,677 in Q3 2025 to a high of $1.43 million in Q3 2021 over five years.
- On a year-over-year basis, Research & Development has increased in each of the last three quarters, with growth averaging 156.4% over the last eight quarters.
- The strongest year-over-year quarter for Research & Development in the past five years was Q1 2026, with growth of 638.3%; the weakest was Q4 2024, with a decline of 90.9%.
- According to Business Quant data, Research & Development for the three prior quarters was $666,405 (Q1 2026), $378,252 (Q4 2025) and $39,677 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 3.65 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 2.34 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 9.74 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | -2.85 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | -4.05 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 1.87 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 1.76 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.81 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 993.80 Mn |
| 10 | Vyome Holdings | 14.25 Mn | -11.86 Mn | 11,658.00 | 506,723.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 506,723.00 |
| Mar 31, 2026 | 666,405.00 |
| Dec 31, 2025 | 378,252.00 |
| Sep 30, 2025 | 39,677.00 |
| Jun 30, 2025 | 80,061.00 |
| Mar 31, 2025 | 90,268.00 |
| Dec 31, 2024 | 67,527.00 |
| Sep 30, 2024 | 66,815.00 |
| Jun 30, 2024 | 399,000.00 |
| Mar 31, 2024 | 484,000.00 |
| Dec 31, 2023 | 739,000.00 |
| Sep 30, 2023 | 542,000.00 |
| Jun 30, 2023 | 581,000.00 |
| Mar 31, 2023 | 453,000.00 |
| Dec 31, 2022 | 462,000.00 |
| Sep 30, 2022 | 583,000.00 |
| Jun 30, 2022 | 747,000.00 |
| Mar 31, 2022 | 745,000.00 |
| Dec 31, 2021 | 270,000.00 |
| Sep 30, 2021 | 1.43 Mn |
API Access
Vyome Holdings Research & Development API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=research-and-development&ticker=HIND&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "research-and-development", "ticker": "HIND", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=research-and-development&ticker=HIND&period=max&api_key=YOUR_API_KEY");
const data = await res.json();